The significant improvements in throughput and quality of DNA sequencing technology have revolutionized our ability to identify the genetic sequence of human cells. High-throughput genome sequencing of tumor cells has furthermore enabled us to identify the complete spectrum of somatically acquired mutations of individual tumors. Among the thousands of somatic mutations that can be found in a given tumor, only a limited number are likely to be of importance for cancer development. A central challenge in cancer genomics research is thus to identify the mutations that are causally implicated in tumorigenesis, commonly known as cancer driver mutations. Genes that carry driver mutations are known as cancer driver genes. Large-scale bioinformatic...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
International audienceCancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved ...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Understanding genetic events that lead to cancer initiation and progression remains one of the bigge...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Abstract Cancer is driven by distinctive sorts of changes and basic variations in genes. Recognizing...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Cancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved in the acquisition of ...
Background: Identifying cancer “driver” genes (CDG) is a crucial step in cancer genomic toward the a...
Abstract: Identifying and distinguishing cancer driver genes among thousands of candidate mutations ...
Cancer is a genomic disease associated with a plethora of gene mutations resulting in a loss of cont...
With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes can now b...
Identifying and distinguishing cancer driver genes among thousands of candidate mutations remains a ...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
International audienceCancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved ...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
The notion that DNA changes could drive the growth of cancer was first speculated more than a centur...
Understanding genetic events that lead to cancer initiation and progression remains one of the bigge...
Cancers are caused by the accumulation of genomic alterations. Driver mutations are required for the...
none3The recent improvement of the high-throughput sequencing technologies is having a strong impact...
Abstract Cancer is driven by distinctive sorts of changes and basic variations in genes. Recognizing...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...
Cancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved in the acquisition of ...
Background: Identifying cancer “driver” genes (CDG) is a crucial step in cancer genomic toward the a...
Abstract: Identifying and distinguishing cancer driver genes among thousands of candidate mutations ...
Cancer is a genomic disease associated with a plethora of gene mutations resulting in a loss of cont...
With the ability to fully sequence tumor genomes/exomes, the quest for cancer driver genes can now b...
Identifying and distinguishing cancer driver genes among thousands of candidate mutations remains a ...
Cancer is an umbrella terminology that binds hundreds of complex genetic diseases based on a set of ...
International audienceCancer driver genes, i.e., oncogenes and tumor suppressor genes, are involved ...
Identifying molecular cancer drivers is critical for precision oncology. Multiple advanced algorithm...